Cargando…
Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981658/ https://www.ncbi.nlm.nih.gov/pubmed/33768824 http://dx.doi.org/10.1002/ccr3.3743 |
_version_ | 1783667557892358144 |
---|---|
author | Andarawewa, Shimalee Aygören‐Pürsün, Emel |
author_facet | Andarawewa, Shimalee Aygören‐Pürsün, Emel |
author_sort | Andarawewa, Shimalee |
collection | PubMed |
description | Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients. |
format | Online Article Text |
id | pubmed-7981658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79816582021-03-24 Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE Andarawewa, Shimalee Aygören‐Pürsün, Emel Clin Case Rep Case Reports Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients. John Wiley and Sons Inc. 2021-02-06 /pmc/articles/PMC7981658/ /pubmed/33768824 http://dx.doi.org/10.1002/ccr3.3743 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Andarawewa, Shimalee Aygören‐Pürsün, Emel Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title | Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title_full | Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title_fullStr | Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title_full_unstemmed | Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title_short | Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE |
title_sort | subcutaneous c1‐inhibitor concentrate for prophylaxis during pregnancy and lactation in a patient with c1‐inh‐hae |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981658/ https://www.ncbi.nlm.nih.gov/pubmed/33768824 http://dx.doi.org/10.1002/ccr3.3743 |
work_keys_str_mv | AT andarawewashimalee subcutaneousc1inhibitorconcentrateforprophylaxisduringpregnancyandlactationinapatientwithc1inhhae AT aygorenpursunemel subcutaneousc1inhibitorconcentrateforprophylaxisduringpregnancyandlactationinapatientwithc1inhhae |